CITIUS ONCOLOGY, INC. (CTOR)
About CITIUS ONCOLOGY, INC.
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $5.6M
- Net income
- -$24.8M
- Total assets
- $100.9M
- Market cap
- $72.5M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $23.5M
- Operating income
- -$23.5M
- Income tax
- $1.1M
- Net income
- -$24.8M
- EPS (basic)
- $-0.34
- EPS (diluted)
- $-0.34
Balance sheet
- Total assets
- $100.9M
- Current assets
- $27.5M
- Total liabilities
- $56.1M
- Current liabilities
- $49.5M
- Shareholders’ equity
- $44.9M
Cash flow
- Operating cash flow
- -$5.5M
- Investing cash flow
- -$5.8M
- Financing cash flow
- $15.2M
- Net cash flow
- $3.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $72.5M
- EPS (diluted)
- $-0.34
- Shares outstanding
- 129.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 13, 2024
Citius Oncology, Inc. (CTOR) Stock Price
- Reported a net loss of $24.8M in FY2026.
- Trading 89% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CITIUS ONCOLOGY, INC..
Write a review
News about CITIUS ONCOLOGY, INC.
News & sentiment via Polygon.io
Citius Oncology, Inc.: frequently asked questions
Is Citius Oncology, Inc. an American company?
Citius Oncology, Inc. is a US-based company headquartered in Cranford, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Citius Oncology, Inc. headquartered?
Citius Oncology, Inc. is headquartered in Cranford, New Jersey, United States.
Is Citius Oncology, Inc. publicly traded?
Yes — Citius Oncology, Inc. is a publicly traded company. Its stock trades under the ticker symbol CTOR on the NASDAQ.
What does Citius Oncology, Inc. do?
Citius Oncology, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
